title: [Dutch guideline for cardiovascular risk management: a consensus model].
abstract: This commentary concerns two major aspects of the guideline, which was revised in 2011 and seems to us the result of a consensus model. The first aspect, namely, of age in relation to cardiovascular risk stratification and the indication that recent studies show that treatment of hypertension of both very old and young people should be considered, is discussed. The second aspect discussed in this commentary, regarding hyperlipidaemia in obesity and diabetes, concerns the argument that apolipoprotein B-100 level or non-HDL cholesterol should specifically be measured for screening and treatment targets.
authors.affiliation: Maastricht Universitair Medisch Centrum, afd. Interne Geneeskunde, Maastricht, the Netherlands. aa.kroon@mumc.nl
authors.forename: A A Bram
authors.initials: AA
authors.lastname: Kroon
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D017410:Practice Guidelines as Topic; D012308:Risk Management
chemical_list: D000959:Antihypertensive Agents; D002317:Cardiovascular Agents